KENNEDY CAPITAL MANAGEMENT LLC

Position in MGTX — MeiraGTx Holdings plc

CIK 884589 ST LOUIS, MO

Position in MGTX

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$7,433,562

+$6,871,195 QoQ

Shares Held

858,379

+1113.5% QoQ

Ownership

0.927%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

KENNEDY CAPITAL MANAGEMENT LLC holds $354,986,312 across 62 Biotechnology names. MGTX ranks #17 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	484,580	$31,318,405
2	CPRX	Catalyst Pharmaceuticals, Inc.	1,199,598	$29,702,046
3	PTGX	Protagonist Therapeutics, Inc	137,099	$14,450,234
4	COGT	Cogent Biosciences, Inc.	360,490	$13,875,260
5	NAMS	NewAmsterdam Pharma Co N.V.	408,492	$13,075,828
6	CORT	Corcept Therapeutics Inc	304,615	$12,279,030
7	CLDX	Celldex Therapeutics, Inc.	352,302	$11,175,019
8	APGE	Apogee Therapeutics, Inc.	122,669	$10,325,049

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,433,562	858,379	+1113.5%	Shares	Sole	2026-05-13
2025-12-31	$562,367	70,738	+2.2%	Shares	Sole	2026-02-13
2025-09-30	$569,869	69,243	+96.8%	Shares	Sole	2025-11-13
2025-06-30	$229,432	35,189	+3.8%	Shares	Sole	2025-08-13
2025-03-31	$229,855	33,902	+1.3%	Shares	Sole	2025-05-13
2024-12-31	$203,826	33,469	+22.7%	Shares	Sole	2025-02-13
2024-09-30	$113,699	27,266	+17.7%	Shares	Sole	2024-11-14
2024-06-30	$97,503	23,160	+40.7%	Shares	Sole	2024-08-14
2024-03-31	$99,893	16,457	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.